Skip to main content
TipRanks
Go Ultimate75% OFF

Simon Pedder Insider Profile

4 Followers

Simon Pedder, Executive Chairman of the Bd, Director at Avalo Therapeutics, holds 241.83K shares in Avalo Therapeutics (Ticker: AVTX), holds ― shares in Delcath Systems (Ticker: DCTH), holds ― shares in Oncotelic Therapeutics (Ticker: OTLC).

Simon Pedder's Trading History

AVTX
Avalo Therapeutics
Apr 13, 2020Executive Chairman of the Bd, DirectorUninformative Sell53.72K$1.88M
ATNXQ
Athenex
Apr 17, 2019―Uninformative Buy―$79.65
CLRB
Cellectar Biosciences
Aug 22, 2014President and CEO, DirectorInformative Buy49.88K$15.16K
OTLC
Oncotelic Therapeutics
―Director――
DCTH
Delcath Systems
―Director――

You May Also Like

Simon Pedder insider profile FAQ

What is the percentage of profitable transactions made by Simon Pedder?
The percentage of profitable transactions made by Simon Pedder is 25%.
What is the average return per transaction made by Simon Pedder?
The average return per transaction made by Simon Pedder is -17.30%.
What stocks does Simon Pedder hold?
Simon Pedder holds: AVTX, DCTH, OTLC, CLRB, ATNXQ stocks.
What was Simon Pedder’s latest transaction?
Simon Pedder’s latest transaction was an Uninformative Sell of $53.72K.
What was Simon Pedder's most profitable transaction?
Simon Pedder’s most profitable transaction was an Informative Buy of ATNXQ stock on November 14, 2018. The return on the trade was 9.60%.
What is Simon Pedder's role in Avalo Therapeutics?
Simon Pedder's role in Avalo Therapeutics is Executive Chairman of the Bd, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.